A strain of influenza appears to have disappeared from the planet since COVID. As a result, U.S. flu vaccines have been ...
Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug ...
Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.